DuPont Nutrition & Health and Seegene Agree to Develop Highly Multiplexed Molecular Assays for Food Safety Testing.

DuPont News, May 25, 2012
George Tice, R&D director, DuPont Qualicon Diagnostics.
(left to right) George Tice, R&D director, DuPont Qualicon Diagnostics, signs joint development agreement with Dr. Jong Yoon Chun, founder and CEO of Seegene, Inc. to develop new, highly multiplexed food safety tests.

 

DuPont Nutrition & Health and Seegene Inc., a leading developer of multiplex molecular technologies and diagnostic tests, have agreed to jointly develop new, highly multiplexed assays for the detection of foodborne pathogens.

“We are constantly seeking innovative collaborators to develop science-based solutions that will meet evolving needs for food safety and quality,” said George Tice, research and development director, DuPont Qualicon Diagnostics.  “This integration of unique Seegene technologies with robust diagnostic systems from DuPont will give the food industry increasingly powerful tools to help protect their products and their brands.”

“Working with DuPont Qualicon Diagnostics opens a significant new market opportunity for our portfolio of multiplex molecular technologies,” said Jong-Yoon Chun, founder and CEO of Seegene. “By leveraging these novel technologies, we can advance from the current ‘one test, one pathogen’ approach to a ‘one test, many pathogens’ paradigm. This will significantly improve the efficiency and effectiveness of food safety testing, and help to reduce the prevalence of foodborne illness.”

Combining the powerful chemistry and analytics of the BAX® System with the novel technologies from Seegene allows for a potential step-change in pathogen testing.